Cargando…
Tissue-Specific Proteomics Analysis of Anti-COVID-19 Nucleoside and Nucleotide Prodrug-Activating Enzymes Provides Insights into the Optimization of Prodrug Design and Pharmacotherapy Strategy
[Image: see text] Nucleoside and nucleotide analogs are an essential class of antivirals for COVID-19 treatment. Several nucleoside/nucleotide analogs have shown promising effects against SARS-CoV-2 in vitro; however, their in vivo efficacy is limited. Nucleoside/nucleotide analogs are often formed...
Autores principales: | Li, Jiapeng, Liu, Shuhan, Shi, Jian, Wang, Xinwen, Xue, Yanling, Zhu, Hao-Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033752/ https://www.ncbi.nlm.nih.gov/pubmed/33855276 http://dx.doi.org/10.1021/acsptsci.1c00016 |
Ejemplares similares
-
Activation of Tenofovir Alafenamide and Sofosbuvir in the Human Lung and Its Implications in the Development of Nucleoside/Nucleotide Prodrugs for Treating SARS-CoV-2 Pulmonary Infection
por: Li, Jiapeng, et al.
Publicado: (2021) -
Synthesis of Nucleoside Phosphate
and Phosphonate
Prodrugs
por: Pradere, Ugo, et al.
Publicado: (2014) -
Advances in antiviral nucleoside analogues and their prodrugs
por: Seley-Radtke, Katherine, et al.
Publicado: (2018) -
Nucleoside diphosphate and triphosphate prodrugs – An unsolvable task?
por: Meier, Chris
Publicado: (2017) -
Advanced prodrug strategies in nucleoside analogues targeting the treatment of gastrointestinal malignancies
por: Xu, Xingxing, et al.
Publicado: (2023)